REDD1 Is Involved in Amyloid β-Induced Synaptic Dysfunction and Memory Impairment

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Alzheimer's disease (AD) is characterized by amyloid beta (Aβ) accumulation and neurodegeneration.
• The role of protein REDD1 (regulated in development and DNA damage response 1) in Aβ pathology and AD pathogenesis remains unclear.
• Understanding REDD1's involvement is crucial for developing novel AD therapeutics.

Purpose of the Study:

• To investigate how Aβ influences REDD1 levels in the brain.
• To determine if REDD1 mediates Aβ-induced synaptic dysfunction.
• To evaluate the therapeutic potential of targeting REDD1 in an AD mouse model.

Main Methods:

• Examined REDD1 expression in mouse hippocampal slices and brains following Aβ exposure.
• Utilized short hairpin RNA (shRNA) to inhibit REDD1 expression.
• Assessed synaptic plasticity and memory function in AD-like mouse models with REDD1 inhibition.

Main Results:

• Aβ exposure increased REDD1 levels in hippocampal slices and brains, suggesting translational regulation.
• Aβ-induced REDD1 upregulation involved the Fyn/ERK/S6 and mGluR5 pathways.
• REDD1 inhibition via shRNA ameliorated Aβ-induced synaptic deficits and memory impairment in mice.

Conclusions:

• REDD1 plays a significant role in Aβ-induced synaptic dysfunction and memory deficits.
• REDD1 is a potential therapeutic target for Alzheimer's disease.
• Further research into REDD1 modulation could lead to effective AD treatments.